Published : 15 May 2014, 12:13 PM
Updated : 23 Apr 2022, 02:44 PM
After an almost year-long investigation, police alleged that William Mark Reilly, a British national and executive of GSK China, and two Chinese executives, Zhang Guowei and Zhao Hongyan, bribed Chinese hospitals, doctors and health institutions, to use their products.
The drugmaker GSK China used illegal means to maximise profit, its former employees alleged during the investigations.
The executives could get up to ten years in jail under Chinese law if the charges of bribery finally stick.
GSK's London headquarters say they had 'no idea of what was going on.'
In a statement, the company said: "We are deeply concerned and are taking these charges very seriously because they go against GSK's business values."
But the GSK itself could also face subsequent charges of 'corporate misbehaviour.'
In a video released by the police to state television, Reilly was accused by a former GSK's Chinese employee Liang Hong as having 'sanctioned the payment for doctors.'